Imperial Innovations increases stake in dental technology specialist OSspray

Imperial Innovations, the technology investor, has boosted its stake in the emerging specialist dental company OSspray following a further drawdown of £980,000 under its existing funding arrangements.
Imperial was the lead investor in the round and invested £650,000. Its co-investors included NESTA and The Capital Fund, managed by Yorkshire Fund Managers.
This follows funding to date of £1,000,000, of which Imperial invested £600,000. The company now has a 31.3% share in OSspray on a fully diluted basis.
OSspray is behind a new dental technology called Sylc, which involves using bioactive glass as a desensitising and cleaning agent for air polishing of teeth.
It has signed distribution arrangements for the UK with Optident Ltd and White Cross GmbH in Germany, and has now launched Sylc in Europe. The technology is also being test marketed in a number of locations in North America.
Susan Searle, the chief executive of Imperial, said the deal was an “excellent demonstration of how we work with early stage companies to take a discovery from the laboratory to successful commercialisation of its products”.
Last week, Imperial sold its 14.3% holding in InforSense Ltd for £0.9 million in cash to data management group IDBS Ltd.

SEARCH Press Releases :